Literature DB >> 8580408

CD34 expression in endothelial cells of small hepatocellular carcinoma: its correlation with tumour progression and angiographic findings.

T Maeda1, E Adachi, K Kajiyama, K Takenaka, H Honda, K Sugimachi, M Tsuneyoshi.   

Abstract

The angiogenic process plays an important role in tumour growth and metastasis during hepatocarcinogenesis, but it is still uncertain when the process begins during tumour formation. Forty-two small hepatocellular carcinomas (HCC) that measured either less than or equal to 2 cm in diameter were studied by comparing the histologic findings with the angiographic findings, and with immunohistochemical expression of endothelial marker QB-end/10 (QB), a new monoclonal antibody raised against CD34, in the sinusoidal wall. Twenty (91%) of 22 moderately or poorly differentiated HCC revealed a positive reaction for QB, while only eight (40%) of 20 well differentiated HCC demonstrated a positive reaction (P < 0.01). In the tumours showing a 'nodule in nodule' appearance, the less differentiated areas were more reactive for QB. Twenty-three (82%) of 28 QB positive tumours were hypervascular, while only three of 14 (21%) QB negative tumours were hypervascular (P < 0.01) by angiography. All six of the poorly differentiated and 13 (81%) of the 16 moderately differentiated tumours were hypervascular, while only seven (35%) of 20 well differentiated HCC were hypervascular (P < 0.01). These results indicate that as the tumour becomes less differentiated, the QB positive areas become wider and angiography demonstrates hypervascularity. We therefore speculate that the HCC sinusoids acquire the characteristics of capillary and precapillary blood vessels during de-differentiation from well to moderate, and thus the tumour begins to reveal hypervascularity on angiography. The above process may be correlated with the stepwise progression of HCC.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8580408     DOI: 10.1111/j.1440-1746.1995.tb01365.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  7 in total

1.  Histological features of early hepatocellular carcinomas and their developmental process: for daily practical clinical application : Hepatocellular carcinoma.

Authors:  Fukuo Kondo
Journal:  Hepatol Int       Date:  2008-11-14       Impact factor: 6.047

Review 2.  Small hepatocellular carcinoma with ring calcification: a case report and literature review.

Authors:  Takashi Murakami; Daisuke Morioka; Hideki Takakura; Yasuhiko Miura; Shinji Togo
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

3.  Microvessel density and clinicopathological characteristics in hepatitis C virus and hepatitis B virus related hepatocellular carcinoma.

Authors:  L Messerini; L Novelli; C E Comin
Journal:  J Clin Pathol       Date:  2004-08       Impact factor: 3.411

4.  Angiopoietin switching regulates angiogenesis and progression of human hepatocellular carcinoma.

Authors:  K Sugimachi; S Tanaka; K Taguchi; S Aishima; M Shimada; M Tsuneyoshi
Journal:  J Clin Pathol       Date:  2003-11       Impact factor: 3.411

5.  Immunohistochemical features of the gastrointestinal tract tumors.

Authors:  Hannah H Wong; Peiguo Chu
Journal:  J Gastrointest Oncol       Date:  2012-09

6.  Relationship of the microvascular type to the tumor size, arterialization and dedifferentiation of human hepatocellular carcinoma.

Authors:  T Yamamoto; K Hirohashi; K Kaneda; T Ikebe; S Mikami; T Uenishi; A Kanazawa; S Takemura; T Shuto; H Tanaka; S Kubo; M Sakurai; H Kinoshita
Journal:  Jpn J Cancer Res       Date:  2001-11

7.  Diagnostic Value of Imaging Methods in the Histological Four Grading of Hepatocellular Carcinoma.

Authors:  Feiqian Wang; Kazushi Numata; Masayuki Nakano; Mikiko Tanabe; Makoto Chuma; Hiromi Nihonmatsu; Akito Nozaki; Katsuaki Ogushi; Wen Luo; Litao Ruan; Masahiro Okada; Masako Otani; Yoshiaki Inayama; Shin Maeda
Journal:  Diagnostics (Basel)       Date:  2020-05-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.